Vaso Corporation (VASO) reported a net loss of $0.2 million for Q2 2025, down from a net income of $1.2 million during the same period last year. Total revenues fell 1.3% to $19.9 million, compared to $20.2 million in Q2 2024. The company’s shares have declined 4.3% following the earnings report.
Key Financial Metrics
Professional sales services revenue dropped 4% to $8.7 million, attributed to decreased imaging equipment deliveries by GE HealthCare, while IT segment revenue increased 0.9% to $10.7 million. Gross profit decreased 2.9% to $11.8 million, resulting in a gross margin of 59%. Selling, general, and administrative expenses rose 11.2% to $12.1 million, contributing to an operating loss of $0.4 million.
Future Outlook
Vaso did not provide specific quantitative guidance for the remainder of 2025 but expressed confidence in ongoing IT recurring revenues and a strong deferred revenue balance of $38.1 million, up from $31.7 million a year earlier. The company will continue focusing on internal growth and partnerships following the termination of its Achari merger agreement.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
